30 closest matches · ranked by relevance
Irritable Bowel Syndrome With Diarrhea
Primary: Response for Relief of Overall IBS Symptoms and of Abdominal Pain/Discomfort at the End of 8 Weeks of Treatment, Where the Response is Defined as at Least 6 Weeks With…
Inflammatory Bowel Diseases · Psychological
Primary: Retention Rate — 23; 25; 19; 22 Participants
Irritable Bowel Syndrome With Diarrhea
Primary: Weekly Response for Abdominal Pain Intensity AND Stool Consistency Over 12 Weeks of Treatment in at Least 50% of the Weeks of Treatment (6 Out of 12 Weeks). — 35.7; 34.7…
Inflammatory Bowel Disease · Perianal Fistula · Perianal Abscess
Primary: Prevalence of Inflammation as Diagnosed by Capsule Endoscopy — 6 participants
Inflammatory Bowel Diseases · Ulcerative Colitis · Crohn Disease
Primary: Prevalence of Anxiety Episodes (Crohn's Disease) — 262; 892 Participants
Inflammatory Bowel Disease
Primary: Percentage of Participants With Active Crohn's Disease (CD) at Day 1 — 16.52; 25.97 percentage of participants
Inflammatory Bowel Disease · Ulcerative Colitis · Crohn's Disease
Primary: Patient Clinical Experience — 1.2; 1.3 units on a scale — p=<0.05
Crohn Disease · Ulcerative Colitis · Inflammatory Bowel Diseases
Primary: Number of Participants With Clinical Remission for Crohn's Disease — 6 Participants
Inflammatory Bowel Disease · Glycogen Storage Disease Type Ia
Primary: Serologic, Genetic and Inflammatory Markers Consistent With Inflammatory Bowel Disease — 11 participants testing positive
Inflammatory Bowel Diseases · Depressive Episode · Recurrent Depressive Disorder
Primary: Stream 1: Percentage of Participants Who Developed Any Mental Health Condition — 12.0; 9.4 percentage of participants
Colitis, Ulcerative
Primary: Remission Rate — 2; 1; 2 Participants
Inflammatory Bowel Disease (IBD)
Primary: Measure Antibody Concentrations in Immunosuppressed IBD Patients Who Receive High Dose and Standard of Care Dose Influenza Vaccine — 160; 160; 160; 160 Antibody Titer
Crohn Disease · Ulcerative Colitis · Inflammatory Bowel Diseases
Primary: Level of Psychological Distress — 60.8; 59.4 T-score
Inflammatory Bowel Disease · Crohn's Disease · Ulcerative Colitis
Primary: Harvey Bradshaw Index — 3.7; 3.2; 4.2 units on a scale
Inflammatory Bowel Disease · Crohn's Disease · Ulcerative Colitis
Primary: Number of Participants Who Responded to Stool Translplantation By 2 Weeks as Determined by Pediatric Ulcerative Colitis Activity Index (PUCAI)/Pediatric Crohn's Disease…
Irritable Bowel Syndrome With Diarrhea
Primary: Change in the Bowel Movements (Stool Frequency) Between the 'Intervention' Group and the 'Placebo' Group Over the Study Period. — .46; .21 bowel movements/day
Crohn's Disease · Ulcerative Colitis · Healthy Controls
Primary: Levels of TNF (Tumor Necrosis Factor Alpha) and TNF-dependent Chemokines (MCP1, MIP-1beta and IP10) in Breast Milk of Women With IBD and Healthy Controls by Multiplex…
Colitis, Ulcerative · Crohn Disease · Inflammatory Bowel Diseases
Primary: Number of Participants Stratified by Treatment Patterns Associated With Biologics Agents Use or Non-biological Therapy in Participants With Moderate to Severe UC and CD…
Inflammatory Bowel Diseases · Clostridium Difficile Infection
Primary: Number of Participants With FMT Failure — 4 Participants
Inflammatory Bowel Disease (IBD) · Crohn's Disease (CD) · Ulcerative Colitis (UC)
Primary: Average Dose of Inflectra at Visit 1 — 457.28; 585.71; 579.44; 449.76 milligram
Irritable Bowel Syndrome
Primary: Response of Overall IBS Symptom Relief - 50% Rule — 79; 61; 61; 78 Participants
Irritable Bowel Syndrome
Primary: Number of Participants With Post Infectious Irritable Bowel Syndrome — 23; 114 participants
Crohn's Disease · Spondyloarthritis
Primary: Number of Participants With MRI Positivity- Global Assessment Positive — 4; 0 Participants
Irritable Bowel Syndrome
Primary: Changes in GIS Scores Between Baseline and After a 12 Week Intervention With Mesalamine or Placebo — 2.72; 2.22 units on a scale — p=.001
Inflammatory Bowel Disease · Crohn's Disease · Ulcerative Colitis
Primary: Pediatric Quality of Life Inventory — 2.14; 1.5; 2.8 score on a scale
Inflammatory Bowel Disease · Behavioral Symptoms
Primary: IBD Symptom Severity — 75.9; 79.9; 63.5; 65.0 Score on a scale — p=0.53
Inflammatory Bowel Disease (IBD)
Primary: Clinical Response — 9 Participants — p=0.03
Inflammatory Bowel Diseases · Clostridium Difficile Infection
Primary: Number of Participants With Clostridium Difficile Recurrence — 4; 1 Participants — p=0.15
Inflammatory Bowel Diseases
Primary: Pre-treatment Serum Level of Endogenous Anti-TNF in Relation to Primary Clinical Response or Non-response — NA endogenous anti-TNF serum level (µg/mL)
Irritable Bowel Syndrome
Primary: Change in Mean Daily Abdominal Pain — 5.2; 5.3; 3.9; 3.8 score on a scale — p=0.78